Aptamer Group plc Share Price

Equities

APTA

GB00BNRRP542

Advanced Medical Equipment & Technology

Market Closed - London S.E. 09:05:17 03/05/2024 pm IST 5-day change 1st Jan Change
0.675 GBX 0.00% Intraday chart for Aptamer Group plc -25.00% -41.30%

Financials

Sales 2022 4.04M 5.06M 422M Sales 2023 1.75M 2.2M 183M Capitalization 4.66M 5.85M 488M
Net income 2022 -2M -2.51M -209M Net income 2023 -7M -8.78M -733M EV / Sales 2022 15.1 x
Net cash position 2022 5.38M 6.75M 563M Net Debt 2023 844K 1.06M 88.35M EV / Sales 2023 3.14 x
P/E ratio 2022
-29.6 x
P/E ratio 2023
-0.59 x
Employees 37
Yield 2022 *
-
Yield 2023
-
Free-Float 68.34%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Aptamer Group plc

1 week-25.00%
Current month-6.90%
1 month+35.00%
3 months-28.95%
6 months-50.00%
Current year-41.30%
More quotes
1 week
0.65
Extreme 0.65
0.83
1 month
0.50
Extreme 0.5
0.90
Current year
0.45
Extreme 0.45
1.40
1 year
0.45
Extreme 0.45
30.50
3 years
0.45
Extreme 0.45
157.00
5 years
0.45
Extreme 0.45
157.00
10 years
0.45
Extreme 0.45
157.00
More quotes
Managers TitleAgeSince
Founder - 01/08/01
Founder 46 01/08/01
Director of Finance/CFO - 01/22/01
Members of the board TitleAgeSince
Director/Board Member 59 21/23/21
Founder 46 01/08/01
Founder - 01/08/01
More insiders
Date Price Change Volume
03/24/03 0.675 0.00% 2,573,613
02/24/02 0.675 0.00% 1,672,184
01/24/01 0.675 -6.90% 2,192,419
30/24/30 0.725 -3.33% 3,972,676
29/24/29 0.75 -16.67% 5,338,187

Delayed Quote London S.E., May 03, 2024 at 09:05 pm IST

More quotes
Aptamer Group plc is a developer of Optimer binders in the life sciences industry. It offers custom Optimer selection and development services. It delivers aptamer-based solutions to its customer bases for a range of therapeutic, diagnostic, and target-binding applications. It develops Optimer binders for therapeutics, diagnostics, bioprocessing, and research applications. The Optimer platform delivers aptamer tools that enables researchers and developers across the spectrum of the life sciences. Optimer binders has developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Optimer act as agonists, antagonists, or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.
More about the company

Annual profits - Rate of surprise